Primary Image

hbcs

Clinical Trial

Research Survey: Answer questions about your experience receiving Home and Community-Based Services (HCBS)

Contact

Niveda Tennety hcbs-rrtc@sralab.org

Objective

The purpose of this study is to test a set of surveys designed to determine if Home and Community-Based Services (HCBS) are person-centered. HCBS are services that help people with disabilities or older adults to live in the community and are paid for by Medicaid. Person-centered HCBS are based on what is important to the person receiving the services and are designed to help the recipient live the life they want to live. In order to determine if HCBS are person-centered, a set of surveys has been developed to measure the person-centeredness (or not) of HCBS. You will be helping to see if the surveys measure what they are intended to measure.

You may be eligible to participate if you:

  • Are a current or former recipient of HCBS
  • Live in the United States
  • Are 18 years old or older
  • Speak and understand English
  • Have access to the internet or a phone

You can complete the eligibility survey here:  

If you are eligible to participate, you will:

  • Participate in a one hour Phone or Zoom consent meeting
  • Complete two, one-hour long surveys about your daily life and your experience with HCBS over the course of two to nine months via Zoom, phone or online
  • You have the option to complete additional surveys

Please note: Accommodations are available.

IRB #: STU00214517

Compensation

A gift card will be provided for each completed interview or online survey (not for the eligibility survey) 

Age Range

18+

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all